MIR325 host gene (non-protein coding) (MIR325HG)

MIR325 host gene (MIR325HG) is classified as a long non-coding RNA gene and is implicated primarily as the genomic locus hosting the sequence for microRNA-325 (miR-325)[3]. While the gene is annotated in genomic databases, direct evidence establishing MIR325HG itself as a functional, therapeutic, or biological target is lacking. The functional significance of MIR325HG independent of its role as a microRNA precursor is unclear. The gene's main association is with the biogenesis of miR-325, a microRNA involved in the post-transcriptional regulation of various target genes. Diseases listed in association with MIR325HG include nephrotic syndrome type 20, but no mechanism or direct therapeutic targeting is reported[3]. Notes on accuracy and nomenclature: - MIR325 host gene (MIR325HG) is not a classical therapeutic target such as a receptor, enzyme, or transporter. There is no canonical receptor, enzyme activity, or well-documented "target" biology directly attributed to MIR325HG itself. - The confusion with "MIR384HG" arises from alternate nomenclature but represents the same locus. However, this further underscores irregular curation and a lack of functional clarity, making it an imprecise or possibly incorrect target for therapeutic purposes at this time[3]. - miR-325, the microRNA produced from this locus, may have biological impact (for example, in cancer or infection pathways), but the gene itself is not a protein-coding or modifiable target by most drug modalities[1][4]. Summary: MIR325 host gene (MIR325HG) is a long non-coding RNA hosting the precursor for microRNA-325. There is currently no clear evidence or consensus establishing MIR325HG itself as a therapeutic target, and the field lacks clear information on its independent disease or biological function[3].

Other names

MIR384HGMIR325HGMIR325 host gene (non-protein coding)